- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Spinal muscular atrophy
- Meeting Date: November 2022
- Public Summary Document (PSD) November 2022 PBAC Meeting - (PDF 1.7MB)
- Public Summary Document (PSD) November 2022 PBAC Meeting - (Word 1.3MB)
Onasemnogene abeparvovec – November 2022
Onasemnogene Abeparvovec: Solution for injection, customised based on patient weight; Zolgensma®
Last updated
17 March 2023